Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis.
Saved in:
| Title: | Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis. |
|---|---|
| Authors: | Tanaka M; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Idei M; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Sakaguchi H; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Kato R; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Sato D; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Sawanobori K; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Kawarasaki S; Office of New Drug 2, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Hata T; Office of New Drug 3, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Yoshizaki A; Office of New Drug 4, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Nakamura M; Office of New Drug 5, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Ikuma M; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 May; Vol. 109 (5), pp. 1265-1273. Date of Electronic Publication: 2020 Nov 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33048367 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tanaka+M%22">Tanaka M</searchLink>; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Idei+M%22">Idei M</searchLink>; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sakaguchi+H%22">Sakaguchi H</searchLink>; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kato+R%22">Kato R</searchLink>; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+D%22">Sato D</searchLink>; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sawanobori+K%22">Sawanobori K</searchLink>; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kawarasaki+S%22">Kawarasaki S</searchLink>; Office of New Drug 2, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hata+T%22">Hata T</searchLink>; Office of New Drug 3, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshizaki+A%22">Yoshizaki A</searchLink>; Office of New Drug 4, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+M%22">Nakamura M</searchLink>; Office of New Drug 5, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ikuma+M%22">Ikuma M</searchLink>; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2021 May; Vol. 109 (5), pp. 1265-1273. <i>Date of Electronic Publication: </i>2020 Nov 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33048367 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.2080 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1265 Titles: – TitleFull: Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tanaka M – PersonEntity: Name: NameFull: Idei M – PersonEntity: Name: NameFull: Sakaguchi H – PersonEntity: Name: NameFull: Kato R – PersonEntity: Name: NameFull: Sato D – PersonEntity: Name: NameFull: Sawanobori K – PersonEntity: Name: NameFull: Kawarasaki S – PersonEntity: Name: NameFull: Hata T – PersonEntity: Name: NameFull: Yoshizaki A – PersonEntity: Name: NameFull: Nakamura M – PersonEntity: Name: NameFull: Ikuma M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2021 May Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 109 – Type: issue Value: 5 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |